key: cord-0970419-52dx2qxe
authors: Yang, Minghui; Lei, Luping; Cao, Qiumei; Yang, Yang; Wang, Jun; Jiang, Xiao; Huang, Kun; Lai, Jinzhi; Qing, Ling; Wang, Yu; Liu, Yingxia
title: Transcriptome Profiling of different types of human respiratory tract cells infected by SARS-CoV-2 Highlight an unique Role for Inflammatory and Interferon Response
date: 2020-11-16
journal: bioRxiv
DOI: 10.1101/2020.11.15.383927
sha: c4ee01752c6da8d33e2130a7002011413a3256fa
doc_id: 970419
cord_uid: 52dx2qxe

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) at the end of 2019 has caused a large global outbreak and now become a major public health issue. Lack of data underlying how the human host interacts with SARS-CoV-2 virus. In the current study, We performed Venn-analysis, Gene ontology (GO), KEGG pathway analysis and Protein-protein interaction analysis of whole transcriptome studies with the aim of clarifying the genes and pathways potentially altered during human respiratory tract cells infected with SARS-CoV-2. We selected four studies through a systematic search of the Gene Expression Omnibus (GEO) database or published article about SARS-CoV-2 infection in different types of respiratory tract cells. We found 36 overlapping upregulated genes among different types of cells after viral infection. Further functional enrichment analysis revealed these DEGs are most likely involved in biological processes related to inflammatory response and response to cytokine, cell component related to extracellular space and I-kappaB/NF-kappaB complex, molecular function related to protein binding and cytokine activity. KEGG pathways analysis highlighted altered conical and casual pathways related to TNF, NF-kappa B, Cytokine-cytokine receptor interaction and IL17 signaling pathways during SARS-CoV-2 infection with CXCL1, CXCL2, CXCL3, CXCL8, CXCL10, IL32, CX3CL1, CCL20, IRF1, NFKB2 and NFKB1A up-regulated which may explain the inflammatory cytokine storms associated with severe cases of COVID-19.

The outbreak of Coronavirus Disease 2019 caused by the novel coronavirus 35 named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was first reported at the 36 end of 2019 [1, 2] . The clinical characteristics of COVID-19 include respiratory symptoms, fever,  37 cough, dyspnea, pneumonia [3-6], acute respiratory distress syndrome (ARDS), and even multiple 38 organ dysfunction in severe cases [7] . Clinical characteristic varied in different COVID -19 39 patients, and a number of patients showed asymptomatic infection [8-10] Recent studies have 40 revealed that asymptomatic cases could also transmit the virus to contacts around them, which 41 makes it more difficult to control the spread of the virus [11] . 42

Several anti-viral drugs have been used to target the SARS-CoV-2 infection. These drugs 43

include lopinavir/ritonavir, penciclovir, chloroquine, hydroxychloroquine, remdesivir, ribavirin 44

[12]. However, most of drugs have limited efficacy to reduce the severity of COVID-19 patients. 45

In addition, some of them have serious side effects [13, 14] . The shortcomings of current tested 46 drugs lead scientists and physicians continuously looking up the better remedies for treatment of 47 COVID-19. Transcriptional profiling has provided remarkable opportunities for understanding the 48 relationship between cellular function and metabolic pathways, as well as to define the possible 49

implications of genetic variability and environmental conditions in many tissues and organisms 50 after viral infection [15, 16] , which could contribute to the screening of drug targets against viruses. 51

In bioinformatics, RNA-Seq analyses are challenging due to its complexity and voluminosity. 52

However, many computational methods and techniques have been developed for the use of the 53 analysis of transcriptomics data. In addition, network-based approach is also extensively used to 54 analyze and identify the potential candidate genes after viral infection [17] . 55

The clinical picture of COVID-19 patients are characterized by an over-exuberant immune 56 response with lung lymphomononuclear cells infilteration and proliferation that may account for 57 tissue damage more than the direct effect of viral replication [18] [19] [20] . Evidence also showed that 58 SARS-CoV-2 infects human respiratory tract cells, prompting inflammation and tissue 59 damage/loss as well as in other different cell types [21] . Despite recent advances, little is known 60 about the pathways involved in viral pathogenesis [22] . In the present study, we performed an 61 analysis of several transcriptome studies, aiming to clarify which genes and cellular networks 62

were up-or down-regulated during SARS-CoV-2 infection in human lung cells. Moreover, we 63 assessed a comprehensive GO enrichment and KEGG pathway analysis to predict how the 64 modulation of these genes could affect the outcome of the disease. 65 

Overlapping and functional enrichment analysis of differential expression genes among The 1,907 different biological process GO terms were further analyzed using OmicsBean software. 98

According to the different levels of the GO terms ( Figure 3A , C), most differential genes were 99 related to positive regulation of immune system process, regulation of immune system process and 100 positive regulation of response to stimulus (level 3 GO), and continued subdivision of the grades 101 showed that the differential genes were involved in the defense response, response to cytokine, 102 cytokine-mediated signaling pathways (level 3-7 GO). According to the number of enriched genes 103 ( Figure 3B ), they mainly enriched in signal transduction (29 differential genes), defense response 104 (24 differential genes), regulation of cell communication (24 differential genes), response to 105 organic substance (23 differential genes), multicellular organism development (22 differential 106 genes) and cellular response to chemical stimulus (20 differential genes). A sorting of the different 107 GO terms based on the P-value and gene number (Figure 3 C,D,E) revealed that these 108

up-regulated genes are most likely involved in biological processes related to inflammatory 109 response and response to cytokine, which indicates that SARS-CoV-2 infection could cause a 110 strong host immune response. 111

The analysis of the 78 different cell components-related GO terms showed that according to the 113 classification of the different GO levels (Figure 4 A), most up-regulated genes were related to continued subdivision identified extracellular region part, membrane-enclosed lumen (level 2 GO) 115

and organelle lumen (level 3 GO), cytoplasm, cytoplasmic part and cytosol (level 4-6 GO). 116

According to the number of enriched genes (Figures 4 B) , the most abundantly enriched 117 up-regulated genes were associated with cytoplasm (27 genes), intracellular organelle (22 genes), 118 intracellular organelle part (20 genes) and vesicle (9 genes). By distinguishing the difference in the 119 P-value of the GO terms and gene number (Figure 4 C,D), we found that these up-regulated genes 120

were enriched in extracellular space and I-kappaB/NF-kappaB complex of cell components. with SARS-CoV-2 will be necessary to decipher the subcellular functions perturbed by this virus 162 and to inform drug development strategies. 163

RNA-Seq has contributed to increase the knowledge relative to the biological and cellular 164 processes involved during viral infection, especially in the context of an emergent pathogen 165 [16, 17] , such as SARS-CoV-2. Venn analysis of several RNA-Seq assays increases the statistical 166

power of samples and we applied this method for re-examining past evidence to better understand 167 the pathogenesis of infections. In our current study, we explored recent SARS-CoV-2 infected 168 cell-derived transcriptome datasets to dissect the cellular and molecular changes in response to 169 SARS-CoV-2 infection. We finally included four available studies and analyzed the gene 170 expression patterns using Venn analysis (Figure 1 ). 171

The revealed that SARS-CoV-2 infection could also trigger cytokine storm in severe cases, 204

accompanied by an increase of various cytokines [45] . In the current study, we found that several 205 cytokine related genes were upregulated after SARS-CoV-2 infection which could provide 206 explanation about the cytokine storms associated with severe COVID-19 cases. 207

Our results highlighted activation of TNF, NF-kappa B, Cytokine-cytokine interaction, IL17 209 signaling pathway and other inflammatory response as the main hallmark associated with 210 SARS-CoV-2 infection in different types of human respiratory epithelial cells in vitro, further 211

identified several differential expressed genes during the course of infection such as IRF1, 212 CXCL1-3, IL32, CXCL10, CX3CL1, CCL20, NFKB2 and so on, which may serve as COVID-19 213

biomarkers. Interferon and inflammatory response to SARS-CoV-2 infection might provide 214 explanation to cytokine storms associated with severe COVID-19 cases. However, precise 215 mechanism in the host response to SARS-CoV-2 remains to be further investigated. 216

We 

A novel coronavirus genome identified in a cluster of 246 pneumonia cases-Wuhan

A Novel Coronavirus from Patients with Pneumonia

Clinical characteristics of 138 hospitalized patients with 2019 250 novel coronavirus-infected pneumonia in Wuhan

Clinical features of patients infected with 2019 novel 252 coronavirus in Wuhan

Early transmission dynamics in Wuhan, China, of novel 254 coronavirus-infected pneumonia

Epidemiological and clinical characteristics of 99 cases of 256 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

A review of coronavirus disease-2019 (COVID-19)

Clinical findings in a group of patients infected with the 2019 259 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical Characteristics of Coronavirus Disease

A familial cluster of pneumonia associated with the 263 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Transmission of 2019-nCoV 266 Infection from an Asymptomatic Contact in Germany

Remdesivir and chloroquine effectively inhibit the 268 recently emerged novel coronavirus (2019-nCoV) in vitro

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with 270

Severe Covid-19

Remdesivir in adults with severe COVID-19: a randomised, 272 double-blind, placebo-controlled, multicentre trial

Expression Analysis Highlights AXL 274 as a Candidate Zika Virus Entry Receptor in Neural Stem Cells

Upon Influenza Virus Infection in Human Cells

Vitro Zika Virus Infection of

Plasma IP-10 and mcp-3 levels are highly associated with 280 disease severity and predict the progression of COVID-19

Response to SARS-CoV-2 and 282 mechanisms of immunopathological changes in COVID-19

Imbalanced Host Response to 284 SARS-CoV-2 Drives Development of COVID-19

Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury

SARS-CoV-2 Receptor ACE2

Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across 289 Tissues

A travel guide to Cytoscape 291 plugins

Coronavirus disease 2019 (COVID-19) Situation Report

An endotoxin-induced serum factor that 294 causes necrosis of tumors

Cachectin and tumour necrosis factor as two sides of the same biological coin

TNF-mediated inflammatory disease

Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune 299 Activation to Viral Reservoirs

Monocyte-Derived Dendritic Cells as Model to Evaluate Species 301 Tropism of Mosquito-Borne Flaviviruses

The role of tumor necrosis factor in modulating responses of murine embryo 303 fibroblasts by flavivirus

Possible new role for NF-κB in the resolution of 305 inflammation

IRF1 Maintains Optimal Constitutive 307 Expression of Antiviral Genes and Regulates the Early Antiviral Response

Interferon regulatory factor 1 restricts 309 gammaherpesvirus replication in primary immune cells

Interferon regulatory factor1 (IRF-1) protects against 311 chikungunya virus induced immunopathology by restricting infection in muscle cells

Mice devoid of interferon regulatory factor 1 (IRF-1) 313 show normal expression of type I interferon genes

Involvement of the IRF-1 315 transcription factor in antiviral responses to interferons

Essential cell-autonomous role for 317 interferon (IFN) regulatory factor 1 in IFNgamma-mediated inhibition of norovirus replication in macrophages

Targeting the cytokine storm for therapeutic benefit

Acute respiratory distress syndrome

Biological features of novel avian influenza A (H7N9) 324 virus

Influenza virus-cytokine-protease cycle in the 326 pathogenesis of vascular hyperpermeability in severe influenza

Characterization of cytokine/chemokine profiles of severe 328 acute respiratory syndrome

Analysis of serum cytokines in patients with severe acute 330 respiratory syndrome

Middle East respiratory syndrome coronavirus (MERS-CoV): infection, 332 immunological response, and vaccine development

Elevated plasma level of selective cytokines in 334 COVID-19 patients reflect viral load and lung injury